Ligand validation:3PJE

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3PJE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PJE_NAD_B_702	79%	6%	0.121	0.966	3.7	1.66	25	8	0	0	100%	1
3PJE_NAD_A_701	65%	6%	0.138	0.942	3.67	1.7	28	8	0	0	100%	1
7UM8_NAD_A_301	96%	5%	0.069	0.976	3.83	1.79	17	12	0	0	100%	1
7UMW_NAD_A_301	95%	3%	0.067	0.972	4.57	1.75	14	8	0	0	100%	1
4D46_NAD_A_1258	92%	46%	0.086	0.976	1.02	1.11	2	6	0	0	100%	1
1QG6_NAD_B_502	90%	7%	0.074	0.958	2.39	2.52	14	15	0	0	100%	1
5CG2_NAD_A_500	90%	63%	0.084	0.966	0.63	0.76	-	1	0	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.